- JP-listed companies
- K Pharma,Inc.
- Balance sheet
K Pharma,Inc.【JP:4896】Balance sheet
Market cap
¥9.2B
P/E ratio
-13.4x
K Pharma develops treatments for neurological diseases like ALS and Alzheimer's using iPS cell technology and regenerative medicine based on Keio University research.
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Cash and cash equivalents | - | 189 | 1,337 | 3,266 | 2,268 | 2,792 |
| Total cash & short-term investments | - | 189 | 1,337 | 3,266 | 2,268 | 2,792 |
| Total current assets | - | 205 | 1,371 | 3,309 | 2,348 | 2,891 |
| Total non-current assets | - | 1 | 4 | 5 | 5 | 48 |
| Total assets | - | 206 | 1,375 | 3,314 | 2,353 | 2,939 |
| Total current liabilities | - | 23 | 34 | 178 | 63 | 102 |
| Total non-current liabilities | - | 4 | 5 | 31 | 31 | 1,572 |
| Total liabilities | - | 27 | 38 | 209 | 95 | 1,674 |
| Retained earnings | - | -621 | -1,013 | -753 | -846 | -993 |
| Stockholders' equity | 8 | 179 | 1,336 | 3,105 | 2,258 | 1,265 |